Service-Tutorial-Lab near Brokenhead MB (52 Result(s))

We are a locally-owned and operated eye health group with two locations in Winnipeg. Our eye health group employs six Doctors of Optometry (ODs) who provide primary vision care. This includes vision correction, as well as the diagnosis and treatment of various eye conditions. A referral to an ophthalmologist is provided when necessary for treatment of eye diseases. We also diagnose and monitor systemic diseases such as hypertension and diabetes (which often first appear in the eye). Each location is equipped with a full-service optical dispensary, supported by technicians and optometric assistants ready to meet your vision needs.

Saving Lives Through Early Disease DiagnosisMiraculins is an emerging biotechnology company committed to extending life, reducing suffering and lowering healthcare costs. Through our leadership in the development and commercialization of diagnostic tests, we strive to improve the overall diagnosis and treatment of patients by enhancing the information available to physicians.The Miraculins AdvantageProducts & ProgramsMiraculins is dedicated to the development and commercialization of diagnostic tests and risk assessment technologies for diseases and conditions that are lacking highly sensitive and specific tests.

Our ProductsAGGRASTAT® - US GP IIb/IIIa inhibitor market - $400 million (AGGRASTAT® + two competitors)TARDOXALTM - in Phase II clinical development for the treatment of Tardive Dyskinesia - a large, unmet needAbout MedicureMedicure is a specialty pharmaceutical company engaged in the research, clinical development and commercialization of human therapeutics.HistoryMedicure founded in 1997 is a specialty pharmaceutical company engaged in the research, clinical development and commercialization of human therapeutics. Medicure has raised over $140 million and focused this investment on the advancement and clinical development of cardiovascular drugs. In 2006 Medicure acquired the USA commercial rights to AGGRASTAT (tirofiban HCl), a cardiovascular drug originally developed by Merck. AGGRASTAT, in combination with heparin, is indicated for the treatment of acute coronary syndrome. Medicurés business is generating revenue to support operations and to make selected investments in the clinical advancement of AGGRASTAT.TodayMedicurés core focus is on the US commercial sales of its FDA approved small molecule, AGGRASTAT.

We are North Forge Technology Exchange – a hybrid incubator/accelerator and the innovation partner for the Province of Manitoba. We fuel Manitoba’s innovation economy providing entrepreneurs with award-winning mentors, rockstar subject matter experts, and a new four-stage Founders Program. We have helped over 60 companies access over 180 million dollars in financing and created hundreds of jobs. Armed with Canada’s largest non-profit fabrication lab, we operate out of 27,000 square feet across Innovation Drive and Innovation Alley in Winnipeg, Canada.

Structure Monitoring Technology Ltd. or SMT, designs software and electronics used to monitor and evaluate the integrity and performance of commercial and residential buildings. Real-time sensor analysis and remote data collection have allowed Engineers and Researchers to validate designs, materials and methods to produce more efficient & durable buildings, reducing their environmental impact while improving quality assurance throughout the construction and/or restoration process. Founded in 2006, SMT has expanded to include low & high value building projects throughout the world. SMT fosters award winning innovation and scientific excellence in both our product lines and services as well as in our commitment to customers, clients, & researchers.SMT has deployed systems across North America ranging from simple wood frame homes, to glass and steel skyscrapers, shopping centers, heritage buildings, art museums, data centers, and national research labs. The Building Intelligence platform addresses the need for automated remote data collection with analytics of building performance trends/events.